99 related articles for article (PubMed ID: 2673713)
1. The influence of cefepime on opsonophagocytosis of bacteria.
Raponi G; Keller N; Rozenberg-Arska M; Hoepelman IM; Verhoef J
Drugs Exp Clin Res; 1989; 15(4):141-4. PubMed ID: 2673713
[TBL] [Abstract][Full Text] [Related]
2. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
3. Enhanced phagocytosis of encapsulated Escherichia coli strains after exposure to sub-MICs of antibiotics is correlated to changes of the bacterial cell surface.
Raponi G; Keller N; Overbeek BP; Rozenberg-Arska M; van Kessel KP; Verhoef J
Antimicrob Agents Chemother; 1990 Feb; 34(2):332-6. PubMed ID: 2109580
[TBL] [Abstract][Full Text] [Related]
4. Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases.
Sougakoff W; Jarlier V
J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():9-14; discussion 63-5. PubMed ID: 11051618
[TBL] [Abstract][Full Text] [Related]
5. Effect of sub-minimal inhibitory concentrations of ciprofloxacin and fleroxacin on the bacterial capsular antigen and opsonophagocytosis by human polymorphonuclear leukocytes.
Keller N; Raponi G; Hoepelman IM; Overbeek BP; Rozenberg-Arska M; Verhoef J
Zentralbl Bakteriol; 1991 Jan; 274(4):519-26. PubMed ID: 1907453
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory and bactericidal activity of cefmetazole and seven other beta-lactams against different bacterial inocula.
Esposito S; Galante D; Barba D
Chemioterapia; 1986 Apr; 5(2):101-4. PubMed ID: 3518963
[TBL] [Abstract][Full Text] [Related]
7. The influence of subminimal inhibitory concentrations of netilmicin and ceftriaxone on the interaction of Escherichia coli with host defences.
Raponi G; Vreede RW; Rozenberg-Arska M; Hoepelman IM; Keller N; Verhoef J
J Antimicrob Chemother; 1989 Apr; 23(4):565-76. PubMed ID: 2663813
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of the in-vitro activity of cefepime and other cephalosporins.
Lim VK; Halijah MY
Malays J Pathol; 1993 Jun; 15(1):65-8. PubMed ID: 8277793
[TBL] [Abstract][Full Text] [Related]
9. Monobactam antibiotics in subinhibitory concentrations enhance opsonophagocytosis and serum bacteriolysis in certain Escherichia coli strains.
Veringa E; Box A; Rozenberg-Arska M; Verhoef J
Drugs Exp Clin Res; 1988; 14(1):1-8. PubMed ID: 3292179
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
11. Bactericidal effect of combinations of cephalosporins with tobramycin on clinical isolates of Escherichia coli, Klebsiella and Staphylococcus aureus.
Wagenvoort JH; Brus-Weijer L; Michel MF
Arzneimittelforschung; 1986 Sep; 36(9):1301-2. PubMed ID: 3539124
[TBL] [Abstract][Full Text] [Related]
12. [Susceptibility of some bacteria isolated from clinical samples to third-generation cephalosporins].
Willke A; Tural D
Mikrobiyol Bul; 1987 Oct; 21(4):279-83. PubMed ID: 3332704
[TBL] [Abstract][Full Text] [Related]
13. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J
Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of cefepime on the phagocytic killing of Staphylococcus aureus by human polymorphonuclear leucocytes and the determination of this effect by means of nitrite production.
Sultan N; Cirak MY; Erbaş D
Microbios; 2000; 103(405):97-106. PubMed ID: 11092191
[TBL] [Abstract][Full Text] [Related]
15. Polyamine effects on antibiotic susceptibility in bacteria.
Kwon DH; Lu CD
Antimicrob Agents Chemother; 2007 Jun; 51(6):2070-7. PubMed ID: 17438056
[TBL] [Abstract][Full Text] [Related]
16. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
Chen MJ; Wang H;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
[TBL] [Abstract][Full Text] [Related]
17. Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
de Sá Del Fiol F; Rocha De Mattos Filho T; Groppo FC
Braz J Infect Dis; 2000 Feb; 4(1):36-42. PubMed ID: 10788844
[TBL] [Abstract][Full Text] [Related]
18. Cefdinir-induced modification of the susceptibility of bacteria to the antibacterial activity of human serum and polymorphonuclear neutrophils.
Pruul H; McDonald PJ
Eur J Clin Microbiol Infect Dis; 1993 Mar; 12(3):170-6. PubMed ID: 8508815
[TBL] [Abstract][Full Text] [Related]
19. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.
Horwitz MA; Silverstein SC
J Clin Invest; 1980 Jan; 65(1):82-94. PubMed ID: 6985617
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
